Beyond Diabetes: The Expanding Benefits of GLP-1 Medications for Weight Loss and More
By: Katherine Fico, PharmD, BCACP Manager, Clinical Initiatives and Pharmacy Collaboration Glucagon-like peptide-1 receptor agonists, better known as GLP-1 medications, were originally designed to lower blood sugar in patients with type 2 diabetes (T2D). Over the last few years, GLP-1 medications, such as semaglutide, have been gaining extraordinary recognition for their ability to help […]
